Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | PTEN wild-type |
Therapy | GSK2256098 |
Indication/Tumor Type | uterine cancer |
Response Type | decreased response |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PTEN wild-type | uterine cancer | decreased response | GSK2256098 | Preclinical | Actionable | In a preclinical study, GSK2256098 treatment resulted in a decreased response in uterine cancer cells with PTEN wild-type versus uterine cancer cells harboring a PTEN mutation (PMID: 25833835). | 25833835 |
PubMed Id | Reference Title | Details |
---|---|---|
(25833835) | PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer. | Full reference... |